Polymorphisms in IGF2/H19 Gene Locus are Associated with Platinum-Based Chemotherapeutic Response in Chinese Patients with Epithelial Ovarian Cancer

References

• McGuire WP , HoskinsWJ , BradyMFet al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer . N. Engl. J. Med.334 ( 1 ), 1 – 6 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Aebi S , CastiglioneM . Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up . Ann. Oncol.19 ( Suppl. 2 ), ii14 – ii16 ( 2008 ).
   PubMedGoogle Scholar
• Ozols RF , BundyBN , GreerBEet al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study . J. Clin. Oncol.21 ( 17 ), 3194 – 3200 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Lottin S , AdriaenssensE , DupressoirTet al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells . Carcinogenesis23 ( 11 ), 1885 – 1895 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Yang F , BiJ , XueXet al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells . FEBS J.279 ( 17 ), 3159 – 3165 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tsang WP , KwokTT . Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells . Oncogene26 ( 33 ), 4877 – 4881 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Zhu Z , SongL , HeJ , SunY , LiuX , ZouX . Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer . Internat. J. Clin. Experiment. Pathol.8 ( 9 ), 10082 – 10091 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Petry Cj , OngKk , BarrattBjet al. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans . BMC Genet.6 ( 22 ), doi:10.1186/1471-2156-6-22 ( 2005 ).
   PubMedGoogle Scholar
• Ross Ja , RadloffGa , SmD . H19 and IGF-2 allele-specific expression in hepatoblastoma . Br. J. Cancer82 ( 4 ), 753 – 756 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Van Gurp RJ , OosterhuisJW , KalscheuerV , MarimanEC , LooijengaLH . Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors . J. Natl Cancer Inst.86 ( 14 ), 1070 – 1075 ( 1994 ).
   PubMedGoogle Scholar
• Gao T , HeB , PanYet al. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway . Clin. Transl. Oncol.16 ( 4 ), 410 – 417 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Taniguchi T , SchofieldAE , ScarlettJL , MorisonIM , SullivanMJ , ReeveAE . Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumor . Oncogene11 ( 4 ), 751 – 756 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Ogawa T , OgawaK , ShigaKet al. Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma . European Arch. Oto-Rhino-Laryngol.267 ( 10 ), 1599 – 1606 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Chen CL , IPSM , ChengD , WongLC , HyN . Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer . Clin. Cancer Res.6 , 474 – 479 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Tao R , HuS , WangSet al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma . Carcinogenesis36 ( 10 ), 1136 – 1143 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Qiu H , LiuQ , LiJet al. Analysis of the association of HOTAIR single nucleotide polymorphism (rs920778) and risk of cervical cancer . APMIS124 ( 7 ), 567 – 573 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Du M , WangW , JinHet al. The association analysis of lncRNA HOTAIR genetic variants and gastric cancer risk in a Chinese population . Oncotarget6 ( 31 ), 31255 – 31262 ( 2015 ).
   PubMedGoogle Scholar
• Li S , HuaY , JinJet al. Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population . Oncotarget7 ( 18 ), 25470 – 25477 ( 2016 ).
   PubMedGoogle Scholar
• Yang C , TangR , MaXet al. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population . Oncotarget6 ( 17 ), 15311 – 15320 ( 2015 ).
   PubMedGoogle Scholar
• Haddad SA , LunettaKL , Ruiz-NarvaezEAet al. Hormone-related pathways and risk of breast cancer subtypes in African American women . Breast Cancer Res. Treatment154 ( 1 ), 145 – 154 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Yoon AJ , ZavrasAI , ChenMK , LinCW , YangSF . Association between Gly1619ARG polymorphism of IGF2R domain 11 (rs629849) and advanced stage of oral cancer . Med. Oncol.29 ( 2 ), 682 – 685 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hoyo C , MurphySK , SchildkrautJMet al. IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites . Dis. Markers32 ( 2 ), 133 – 141 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Couvert P , CarriéA , Tezenas Du MontcelSet al. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma . Clin. Res. Hepatol. Gastroenterol.36 ( 4 ), 345 – 351 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gong W-J , YinJ-Y , LiX-Pet al. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response . Tumor Biol.37 ( 6 ), 8349 – 8358 ( 2016 ).
   PubMedGoogle Scholar
• Murrell A , HeesonS , CooperWNet al. An association between variants in the IGF2 gene and Beckwith–Wiedemann syndrome: interaction between genotype and epigenotype . Hum. Mol. Genet.13 ( 2 ), 247 – 255 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Petry CJ , SeearRV , WingateDLet al. Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy . Diabetes60 ( 11 ), 3090 – 3096 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liu Y , TangY , YeDet al. Impact of abnormal DNA methylation of imprinted loci on human spontaneous abortion . Reprod. Sci.25 ( 1 ), 131 – 139 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Dong Y , LiJ , HanFet al. High IGF2 expression is associated with poor clinical outcome in human ovarian cancer . Oncol. Rep.34 ( 2 ), 936 – 942 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Huang GS , Brouwer-VisserJ , RamirezMJet al. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer . Clin. Cancer Res.16 ( 11 ), 2999 – 3010 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Brouwer-Visser J , LeeJ , McCullaghK , CossioMJ , WangY , HuangGS . Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer . PLoS ONE9 ( 6 ), e100165 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pearce CL , DohertyJA , Van Den BergDJet al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk . Hum. Mol. Genet.20 ( 11 ), 2263 – 2272 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhu QN , WangG , GuoYet al. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway . Oncotarget8 ( 54 ), 91990 – 92003 ( 2017 ).
   PubMedGoogle Scholar
• Matouk IJ , RavehE , Abu-LailRet al. Oncofetal H19 RNA promotes tumor metastasis . Biochim. Biophys. Acta1843 ( 7 ), 1414 – 1426 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zheng ZG , XuH , SuoSSet al. The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer . Sci Rep6 , 26093 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Francis-Thickpenny KM , RichardsonDM , Van EeCCet al. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma . Br. J. Cancer85 ( 5 ), 687 – 691 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Jones S , WangTL , Shih IeMet al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma . Science (New York)330 ( 6001 ), 228 – 231 ( 2010 ).
   Google Scholar
• Sato N , TsunodaH , NishidaMet al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary . Cancer Res.60 ( 24 ), 7052 – 7056 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Wiegand KC , LeeAF , Al-AghaOMet al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas . J. Pathol.224 ( 3 ), 328 – 333 ( 2011 ).
   PubMed Web of Science ®Google Scholar